Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Morgonrapport
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Transkriptioner
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Aktieanalys utförd av tredje part

Nolato: An unexpected hiccup in the earnings trend - ABG

Nolato

Detta är en aktieanalys producerad av tredje part och reflekterar därför nödvändigtvis ej våra åsikter och värderingar

Ladda ner rapporten (PDF)
* A surprising sequential margin decline in Q4...
* ... but we see no structural issues behind it
* EBITA lowered by 5-3%, share now at 13.2x '26e EV/EBITA

An unexpected sequential margin drop
Nolato reported Q4 sales in line with IR consensus (2% below ABGSCe), but saw a substantial and unexpected sequential adj. EBITA margin drop of 1.3pp to 10.4% (ABGSCe 11.9%, cons. 11.6%). This follows four consecutive quarters of q-o-q margin expansion, and thus it caught us off guard. This was driven by: 1) start-up costs for new medical products in the US, 2) an unusually large winter holiday impact, and 3) higher COGS related to precious metal prices, while Nolato's price hikes to its customers come with a lag effect. Although there may be some lingering margin headwinds into the coming quarters as well, we stress that we see these factors as temporary and from a long term perspective, we argue they do not impact Nolato's ability to reach its 12% EBITA margin target.

EBITA lowered by 5-3%, of which -2pp from FX
We lower our EBITA estimates by 5-3% for '26e-'27e, of which -2pp per year stems from updated FX assumptions. The remainder stems from lowered margin assumptions for Engineered Solutions.

Share trading at 13.2-11.5x '26e-'27e EV/EBITA
The Q4 numbers were disappointing, but carry no structural implications on Nolato's profitability, in our view. The share is now trading at 13.2-11.5x '26e-'27e EV/EBITA vs. its historical average multiple of 15.2x, and it currently offers FCF yields of 5-6%. Finally, we highlight that we see accelerating organic growth from Q3'26e driven by the ramp-up of the new expansion in Hungary, which the company reiterated on the conference call is progressing according to plan.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.